Literature DB >> 21980833

Effect of glucocorticoid in mice of asthma induced by ovalbumin sensitisation and RSV infection.

Xiang-yu Chi1, Shu-juan Jiang, Jing Wang, Jian-ping Wang.   

Abstract

OBJECTIVE: To investigate the inflammatory changes and the airway hyper-responsiveness in the asthma mouse model infected by respiratory syncytial virus and elucidate the relationship between the infection and the effect of glucocorticoid.
METHODS: 60 BALB/c mice were randomly divided into 6 groups. One of these is the control group; the others are the OVA/sham group, the OVA/sham +Dex group, the PBS/RSV group, the OVA/RSV group and the OVA/RSV+Dex group. The airway resistance was measured using a sealed body plethysmograph. Pathological slides were stained with hematoxylin-eosin, and the peribronchial inflammation was observed microscopically. The concentrations of IL-4, IFN-gamma, TGF-beta1 in lung tissues were detected by ELISA.
RESULTS: Compared with the control group, the degree of the airway inflammation and hyperresponsiveness and the concentrations of IL-4/IFN-gamma, TGF-beta1 in all four OVA groups increased significantly. And there was a statistically significant difference between the OVA/sham group and the OVA/sham+Dex group, and between the OVA/RSV group and the OVA/RSV+Dex group respectively. Compared with the OVA/RSV group, there was an obvious aggravation of airway inflammation and hyper-responsiveness in the OVA/RSV+Dex group.
CONCLUSIONS: Glucocorticoid significantly reduces airway inflammation and hyper-responsiveness induced by repetitive OVA challenge in the mouse model of asthma. However, the significant decrease in Th1 and increase in Th2 inflammation and aggravation of airway hyper-responsiveness in the mice in OVA/RSV group show that they are not sensitive to glucocorticoid. The effects of infection with RSV on the mouse model of asthma could be the cause of the glucocorticoid resistance during the therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21980833

Source DB:  PubMed          Journal:  Asian Pac J Allergy Immunol        ISSN: 0125-877X            Impact factor:   2.310


  5 in total

1.  Roflumilast improves corticosteroid resistance COPD bronchial epithelial cells stimulated with toll like receptor 3 agonist.

Authors:  Javier Milara; Anselm Morell; Bea Ballester; Celia Sanz; Jose Freire; Xiaozhong Qian; Maggie Alonso-Garcia; Esteban Morcillo; Julio Cortijo
Journal:  Respir Res       Date:  2015-02-05

2.  Effects of Laminaria japonica polysaccharides on airway inflammation of lungs in an asthma mouse model.

Authors:  Rongjun Lin; Xiaomei Liu; Yan Meng; Mei Xu; Jianping Guo
Journal:  Multidiscip Respir Med       Date:  2015-06-11

Review 3.  Respiratory Viral Infections in Exacerbation of Chronic Airway Inflammatory Diseases: Novel Mechanisms and Insights From the Upper Airway Epithelium.

Authors:  Kai Sen Tan; Rachel Liyu Lim; Jing Liu; Hsiao Hui Ong; Vivian Jiayi Tan; Hui Fang Lim; Kian Fan Chung; Ian M Adcock; Vincent T Chow; De Yun Wang
Journal:  Front Cell Dev Biol       Date:  2020-02-25

Review 4.  Respiratory Syncytial Virus: Targeting the G Protein Provides a New Approach for an Old Problem.

Authors:  Ralph A Tripp; Ultan F Power; Peter J M Openshaw; Lawrence M Kauvar
Journal:  J Virol       Date:  2018-01-17       Impact factor: 5.103

5.  The endogenous Th17 response in NO2-promoted allergic airway disease is dispensable for airway hyperresponsiveness and distinct from Th17 adoptive transfer.

Authors:  Rebecca A Martin; Jennifer L Ather; Rebecca Daggett; Laura Hoyt; John F Alcorn; Benjamin T Suratt; Daniel J Weiss; Lennart K A Lundblad; Matthew E Poynter
Journal:  PLoS One       Date:  2013-09-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.